Science & Technology Watch: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Science & Technology Watch.

Press releases published on September 28, 2026

Sep. 28, 2026

Kaltura Wins Best Interactive Content Platform in the 2026 Digiday Technology Awards

Indeterminate GlobeNewswire

Sep. 28, 2026

COMSTOCK ANNOUNCES SIGNING OF FRAMEWORK AGREEMENT FOR $1.65 BILLION STRATEGIC PARTNERSHIP WITH SOCAR

Indeterminate GlobeNewswire

Sep. 28, 2026

Keros Therapeutics Announces the First Patient Dosing in the Phase 2 Clinical Trial Evaluating Rinvatercept in DMD

Indeterminate GlobeNewswire

Sep. 28, 2026

ROC Secures $64.3 Million U.S. Department of Justice Contract for Digital Evidence Technology

Indeterminate GlobeNewswire

Sep. 28, 2026

NETSOL Technologies reports record fiscal 2026 revenue and full-year profitability, exceeding guidance

Indeterminate GlobeNewswire

Sep. 28, 2026

Curonix Announces Published PNS IMPACT Clinical Study Showing Freedom® Peripheral Nerve Stimulator (PNS) System is Associated with Reductions in Pain Scores, Opioid Use and Overall Patient Burden

Indeterminate GlobeNewswire

Sep. 28, 2026

Lantheus Announces First Patient Dosed in SPARROW Phase 2/3 Registrational Trial in Prostate Cancer

Indeterminate GlobeNewswire

Sep. 28, 2026

Humacyte Expands Board Expertise with Appointment of Scott Coward and Paul Kuznik

Indeterminate GlobeNewswire

Sep. 28, 2026

4DMT Advances 4D-150 into Phase 3 for Second Large Market Retina Indication with Initiation of 4SIGHT in DME

Indeterminate GlobeNewswire

Sep. 28, 2026

Route 92 Medical Announces U.S. FDA Clearance for the FreeClimb® 46 Catheter with Tenzing® 4

Indeterminate GlobeNewswire

Sep. 28, 2026

Core Molding Technologies Promotes Michael J. Gayford to Chief Operating Officer

Indeterminate GlobeNewswire

Sep. 28, 2026

ALX Oncology Announces Nature Medicine Publication of ASPEN-06 Phase 2 Clinical Data Demonstrating Strong Responses and Durable Clinical Benefit with Evorpacept in HER2-Positive Gastric Cancer

Indeterminate GlobeNewswire

Sep. 28, 2026

icMercury Selected for In-Orbit Validation Mission Aboard PocketQube Satellite on SpaceX Transporter-18

Indeterminate GlobeNewswire

Sep. 28, 2026

ReconAfrica Resumes Operations at Kavango West 1X Ahead of Horizontal Flow Test and Provides Updates on KW1X Flow Test Samples, Angola Soil Sampling and Gabon Seismic Reprocessing

Indeterminate GlobeNewswire

Sep. 28, 2026

ORYZON Receives European Medicines Agency Approval to Initiate the HOPE-2 Phase II Study of Vafidemstat for the Treatment of Phelan-McDermid Syndrome (PMS)

Indeterminate GlobeNewswire

Sep. 28, 2026

GOWell Energy Technology Commences Trading on Nasdaq Under Ticker Symbol "GOW”

Indeterminate GlobeNewswire

Sep. 28, 2026

NeOnc Technologies Announces FDA End of Phase 1 Meeting for NEO212

Indeterminate GlobeNewswire

Sep. 28, 2026

Callio Therapeutics Appoints Chris Hassig, PhD, as Chief Scientific Officer

Indeterminate GlobeNewswire

Sep. 28, 2026

Fobi AI (TSXV: FOBI) Issues Corporate Update on Business Transition; Schedules Live Product Demo for October 7

Indeterminate GlobeNewswire

Sep. 28, 2026

Aemetis Receives $22.4 million from Sale of Section 45Z Clean Fuel Production Tax Credits

Indeterminate GlobeNewswire